Twenty-Four–Month Continuation of Reversible Contraception
O'Neil-Callahan M, Peipert J, Zhao Q, Madden T, Secura G. Twenty-Four–Month Continuation of Reversible Contraception. Obstetrics And Gynecology 2013, 122: 1083-1091. PMID: 24104781, PMCID: PMC4012225, DOI: 10.1097/aog.0b013e3182a91f45.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBody Mass IndexCohort StudiesContraceptionContraceptive Agents, FemaleContraceptives, OralFemaleFollow-Up StudiesHumansInterviews as TopicIntrauterine DevicesIntrauterine Devices, CopperLevonorgestrelMedroxyprogesterone AcetateParityProspective StudiesRisk FactorsSocioeconomic FactorsYoung AdultConceptsNon-LARC methodsContinuation ratesContraceptive CHOICE ProjectReversible contraceptionContraceptive methodsFirst-line contraceptive optionProspective observational cohort studyContraceptive method discontinuationImplant continuation ratesMonth continuation ratesObservational cohort studyMonths of enrollmentHigh continuation ratesReversible contraceptive methodsCHOICE ProjectShort-acting methodsCohort studyMethod discontinuationContraceptive optionsLARC methodsUnintended pregnancyIntrauterine deviceCost contraceptionLower riskCopper IUD